Clinical Trial Update: Delayed Tolerance Through Mixed Chimerism [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes Phase 1/Phase 2 efforts to induce delayed tolerance in kidney transplant recipients using mixed chimerism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Kidney Failure, Kidney Transplant; Complications | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING